Molecula Health Limited 13806873 true 2025-01-01 2025-12-31 2025-12-31 The principal activity of the company is Wholesale of pharmaceutical goods Digita Accounts Production Advanced 6.30.9574.0 true Mr Rezo Tsulukidze Mr Rati Bokolishvili 13806873 2025-01-01 2025-12-31 13806873 2025-12-31 13806873 core:ShareCapital 2025-12-31 13806873 core:CurrentFinancialInstruments 2025-12-31 13806873 bus:FRS102 2025-01-01 2025-12-31 13806873 bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 13806873 bus:FullAccounts 2025-01-01 2025-12-31 13806873 bus:Director2 2025-01-01 2025-12-31 13806873 bus:Director3 2025-01-01 2025-12-31 13806873 bus:EntityHasNeverTraded 2025-01-01 2025-12-31 13806873 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 13806873 countries:AllCountries 2025-01-01 2025-12-31 13806873 2024-12-31 13806873 core:ShareCapital 2024-12-31 13806873 core:CurrentFinancialInstruments 2024-12-31 iso4217:GBP

Registration number: 13806873

Molecula Health Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 December 2025

 

Molecula Health Limited

(Registration number: 13806873)
Balance Sheet as at 31 December 2025

Note

2025
£

2024
£

Current assets

 

Debtors

100

100

Capital and reserves

 

Called up share capital

100

100

Shareholders' funds

 

100

100

For the financial year ending 31 December 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 29 July 2026 and signed on its behalf by:
 

.........................................
Mr Rezo Tsulukidze
Director